Td Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Td Asset Management Inc

  • $106 Billion
  • Q4 2024

A detailed history of Td Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 142,396 shares of SRPT stock, worth $15.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
142,396
Previous 142,396 -0.0%
Holding current value
$15.1 Million
Previous $17.8 Million 2.65%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$124.33 - $156.75 $2.07 Million - $2.62 Million
-16,686 Reduced 10.49%
142,396 $17.8 Million
Q2 2024

Aug 02, 2024
SELL
$113.33 - $163.85 $1.98 Million - $2.87 Million
-17,490 Reduced 9.91%
159,082 $25.1 Million
Q1 2024

May 08, 2024
SELL
$93.7 - $141.53 $2.86 Million - $4.32 Million
-30,540 Reduced 14.75%
176,572 $22.9 Million
Q4 2023

Feb 12, 2024
BUY
$67.31 - $124.76 $167,332 - $310,153
2,486 Added 1.21%
207,112 $20 Million
Q3 2023

Oct 27, 2023
BUY
$102.5 - $123.59 $16.6 Million - $20 Million
161,788 Added 377.67%
204,626 $24.8 Million
Q2 2023

Aug 09, 2023
SELL
$106.4 - $157.19 $1.73 Million - $2.56 Million
-16,300 Reduced 27.56%
42,838 $4.91 Million
Q1 2023

May 10, 2023
BUY
$117.53 - $155.99 $2.22 Million - $2.95 Million
18,916 Added 47.03%
59,138 $8.15 Million
Q4 2022

Feb 06, 2023
SELL
$100.86 - $132.13 $104,390 - $136,754
-1,035 Reduced 2.51%
40,222 $5.21 Million
Q3 2022

Nov 07, 2022
SELL
$75.71 - $119.24 $225,464 - $355,096
-2,978 Reduced 6.73%
41,257 $4.52 Million
Q2 2022

Aug 04, 2022
BUY
$62.69 - $88.44 $106,573 - $150,348
1,700 Added 4.0%
44,235 $3.32 Million
Q1 2022

May 10, 2022
BUY
$63.15 - $90.42 $934,620 - $1.34 Million
14,800 Added 53.36%
42,535 $3.32 Million
Q2 2021

Aug 11, 2021
SELL
$69.38 - $86.75 $977,286 - $1.22 Million
-14,086 Reduced 33.68%
27,735 $1.88 Million
Q1 2021

May 14, 2021
SELL
$72.25 - $168.95 $182,648 - $427,105
-2,528 Reduced 5.7%
41,821 $3.12 Million
Q4 2020

Feb 16, 2021
SELL
$125.56 - $178.74 $358,473 - $510,302
-2,855 Reduced 6.05%
44,349 $7.56 Million
Q3 2020

Nov 10, 2020
BUY
$127.12 - $172.34 $748,609 - $1.01 Million
5,889 Added 14.25%
47,204 $6.63 Million
Q2 2020

Aug 13, 2020
BUY
$93.0 - $171.7 $355,446 - $656,237
3,822 Added 10.19%
41,315 $6.62 Million
Q1 2020

May 15, 2020
SELL
$82.38 - $131.64 $3.42 Million - $5.46 Million
-41,500 Reduced 52.54%
37,493 $3.67 Million
Q4 2019

Feb 11, 2020
SELL
$76.53 - $135.58 $1.09 Million - $1.92 Million
-14,196 Reduced 15.23%
78,993 $10.2 Million
Q3 2019

Nov 07, 2019
BUY
$72.81 - $156.91 $73,392 - $158,165
1,008 Added 1.09%
93,189 $7.02 Million
Q2 2019

Aug 01, 2019
BUY
$112.21 - $151.95 $1.04 Million - $1.41 Million
9,300 Added 11.22%
92,181 $14 Million
Q1 2019

May 08, 2019
SELL
$106.67 - $151.68 $1.24 Million - $1.76 Million
-11,582 Reduced 12.26%
82,881 $9.88 Million
Q4 2018

Feb 01, 2019
BUY
$97.32 - $148.76 $661,776 - $1.01 Million
6,800 Added 7.76%
94,463 $10.3 Million
Q3 2018

Nov 01, 2018
SELL
$115.31 - $161.51 $788,374 - $1.1 Million
-6,837 Reduced 7.23%
87,663 $14.2 Million
Q2 2018

Jul 31, 2018
BUY
$71.74 - $153.69 $1.69 Million - $3.63 Million
23,600 Added 33.29%
94,500 $12.5 Million
Q1 2018

May 11, 2018
BUY
$54.02 - $82.27 $1.83 Million - $2.78 Million
33,800 Added 91.11%
70,900 $5.25 Million
Q4 2017

Feb 02, 2018
BUY
$47.64 - $56.75 $843,228 - $1 Million
17,700 Added 91.24%
37,100 $2.06 Million
Q3 2017

Nov 09, 2017
BUY
$35.73 - $47.15 $693,161 - $914,710
19,400
19,400 $880,000

Others Institutions Holding SRPT

# of Institutions
536
Shares Held
87.4M
Call Options Held
1.55M
Put Options Held
1.35M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.31B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email